Nurses are in a prime position to prevent pediatric medication errors
The inability to calculate therapeutic dosages for children accounts for the majority of pediatric drug errors, according to Ronda G. Hughes, PhD, MHS, RN, and Elizabeth A. Edgerton, MD, MPH, of the Agency for Healthcare Research and Quality. But there are practical ways for nurses-who often have primary responsibility for ensuring patient safety in the hospital and are usually the providers who administer the medications-to reduce the likelihood of a mistake.
The approval is based on BRAVE-AA-PEDS, in which 42% of adolescents receiving baricitinib 4 mg achieved at least 80% scalp hair coverage at week 36 vs 5% with placebo.
Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.
The latest IDSA histoplasmosis update adds a consensus statement on severe disease and outlines when children with pulmonary infection warrant itraconazole therapy.